1990至2021年全球特应性皮炎疾病负担趋势分析
基于全球疾病负担研究2021数据库,分析1990至2021年特应性皮炎的患病率、发病率及伤残调整寿命年趋势。高收入地区、女性及5岁以下儿童负担最高,所有社会人口指数地区负担均下降。
要点
- 年龄标化患病率略降,2021年为每10万人1728.5例。
- 高收入地区、女性和5岁以下儿童负担最高。
核心结论
- 全球AD患病负担在高收入国家、女性和幼儿中最高,但所有社会人口指数地区负担均下降。
研究设计与样本
- 基于全球疾病负担研究2021数据库的趋势分析,分析患病率、发病率和伤残调整寿命年。
主要发现
- 年龄标化患病率同期略降,2021年为每10万人1728.5例。
- 高收入地区负担最高,女性和5岁以下儿童患病 notable。
- 所有社会人口指数地区负担均下降,高社会人口指数国家下降最显著。
- 南亚患病率最高,印度、中国和美国病例数最多。
局限性
- 数据来源和质量存在差异,缺乏严重程度和环境因素数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Globally, atopic dermatitis (AD) is highly prevalent; however, there is a paucity of research focusing on its burden and trends. OBJECTIVE: To understand the current epidemic situation of AD and to suggest measures that may help reduce its global burden. METHODS: Global trends of AD, including prevalence, incidence, and disability-adjusted life-years, were analyzed using data from the Global Burden of Disease Study database 2021. RESULTS: In 2021, the global prevalence of AD reached 129 million cases, reflecting a 20% increase since 1990. However, the age-standardized prevalence rate decreased slightly during the same period, measuring 1728.5 per 100,000 individuals in 2021. The highest burden of AD was observed in high-income regions, with a notable prevalence among females and children under 5 years of age. However, the burden decreased across all sociodemographic index regions, with the most significant decline in high sociodemographic index countries. Regionally, South Asia reported the highest prevalence, while globally, India, China, and the United States exhibited the highest number of cases. LIMITATIONS: Variations in data sources and quality, and the absence of data regarding severity and environmental factors. CONCLUSION: The global burden of AD prevalence was highest in high-income countries and among females and young children.
引用
- Sun C, Zhang X, Su Z, et al. Global, regional, and national burdens of atopic dermatitis from 1990 to 2021: A trend analysis from the Global Burden of Disease Study 2021. J Am Acad Dermatol. 2025. PMID: 40543661. doi:10.1016/j.jaad.2025.06.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。